MoneyWorks4Me

Nutraplus India - Quaterly Results

21 Sep 2024 Evaluate
The Sales for the quarter ended June 2020 of Rs. 0.09 million declined by -99.97% from Rs. 315.86 millions.The Net Loss for the quarter ended June 2020 is Rs. -12.78 millions as compared to Net Profit of Rs. 1.76 millions of corresponding quarter ended June 2019Operating profit Margin for the quarter ended June 2020 slipped to -0.12% as compared to 29.52% of corresponding quarter ended June 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 0.09 315.86 -99.97 0.09 315.86 -99.97 1066.69 1395.56 -23.57
Other Income 0.30 0.38 -21.05 0.30 0.38 -21.05 1.44 38.76 -96.28
PBIDT -0.12 29.52 -100.41 -0.12 29.52 -100.41 -356.93 165.29 -315.94
Interest 0.68 15.96 -95.74 0.68 15.96 -95.74 74.32 68.52 8.46
PBDT -0.80 13.56 -105.90 -0.80 13.56 -105.90 -431.25 73.92 -683.40
Depreciation 11.98 11.80 1.53 11.98 11.80 1.53 47.01 40.30 16.65
PBT -12.78 1.76 -826.14 -12.78 1.76 -826.14 -478.26 33.62 -1522.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.74 -100.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.52 -100.00
PAT -12.78 1.76 -826.14 -12.78 1.76 -826.14 -478.26 21.88 -2285.83
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) -133.33 9.35 -1526.65 -133.33 9.35 -1526.65 -33.46 11.84 -382.52
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..